/PRNewswire/ Cure, a healthcare innovation campus, in partnership with Makovsky, a leading independent communications consultancy, will bring together New.
US News: Indian-American entrepreneur Vivek Ramaswamy's presidential campaign is gaining momentum, with his performance in the GOP debates earning him a place
Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) hit a new 52-week high during mid-day trading on Friday after Citigroup raised their price target on the stock from $11.00 to $14.00. Citigroup currently has a buy rating on the stock. Roivant Sciences traded as high as $9.08 and last traded at $8.87, with a […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating)’s stock price traded up 9.1% on Wednesday . The company traded as high as $4.12 and last traded at $4.08. 17,311 shares changed hands during trading, a decline of 97% from the average session volume of 540,391 shares. The stock had previously closed at $3.74. A number of […]